CWP
EDIT icon

Concord Wealth Partners’s Editas Medicine EDIT Stock Holding History

Concord Wealth Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14
Closed – – 1264
2022
Q1 		$0 Sell
14
-26
-65% -$483 ﹤0.01% 1309
2021
Q4 		$1K Sell
40
-33
-45% -$1.14K ﹤0.01% 1208
2021
Q3 		$3K Sell
73
-71
-49% -$3.89K ﹤0.01% 677
2021
Q2 		$8K Buy
144
+97
+206% +$3.58K ﹤0.01% 655
2021
Q1 		$2K Sell
47
-595
-93% -$33.9K ﹤0.01% 820
2020
Q4 		$45K Buy
+642
New +$26.4K 0.03% 220

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Concord Wealth Partners's EDIT Position: Q2 2022 in Review

Concord Wealth Partners sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 14 shares.

Concord Wealth Partners first reported a position in EDIT in Q4 2020 and held it in 6 quarters. The position peaked at $45K in Q4 2020. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • Concord Wealth Partners reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • Concord Wealth Partners sold 14 Editas Medicine shares in Q2 2022.
  • Concord Wealth Partners first reported a position in Editas Medicine in Q4 2020 and held it in 6 quarters.
  • Concord Wealth Partners's Editas Medicine position peaked at $45K in Q4 2020.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on Concord Wealth Partners's 13F filing for Q2 2022, filed 4 Aug 2022.